Stock Taper 
| DATE | TYPE | RATIO |
|---|---|---|
| 2002-03-08 | Forward | 2:1 |
| 1996-06-03 | Forward | 3:2 |
| 1986-06-11 | Forward | 3:2 |
| 1985-08-01 | Forward | 3:2 |
| 1980-03-18 | Forward | 2:1 |
Bio-Rad Laboratories, Inc. develops and distributes life science research and clinical diagnostic products globally, serving research, biopharmaceutical, food safety, and clinical laboratories through its Life Science and Clinical Diagnostics segm...
The QX700 is a high-throughput, seven-color multiplexing Droplet Digital PCR system capable of processing over 700 samples daily, serving academic, gene therapy, and biopharma applications with advanced genetic analysis.
Bio-Rad Laboratories announced second-quarter 2025 financial results that significantly exceeded analyst expectations, with earnings per share of $2.61 beating the consensus estimate of $1.76 and sales of $651.6 million surpassing the estimated $615.11 million. This strong performance, coupled with an updated and more optimistic full-year financial outlook, led to a surge in the company's stock price and positive commentary from the investment community.
Bio-Rad entered into a binding offer in February 2025 and completed the acquisition of Stilla Technologies by the second quarter. This move strategically enhances Bio-Rad's Droplet Digital PCR (ddPCR) portfolio with next-generation platforms, aiming to expand its market share in high-growth areas like oncology, cell and gene therapy, and applied research.
Presentation to feature results from first clinical study of ART26.12 and highlight the potential of FABP5 inhibition across multiple indications
Oncotelic's AI drug discovery platform invites scientists, developers and biotech founders to connect computational discovery with drug development. Source: Oncotelic Therapeutics, Inc. AGOURA HILLS, Calif.
Overall rating: B
| PEER | PRICE | |
|---|---|---|
 TMO | $648.43 | COMPARE |
 DHR | $215.89 | COMPARE |
 RVTY | $150.45 | COMPARE |
 CRL | $306.27 | COMPARE |
 PEN | $317.31 | COMPARE |
 DVA | $180.94 | COMPARE |
 TECH | $72.48 | COMPARE |
 GMED | $76.92 | COMPARE |
